Basic Information
| RNALocate ID: | RLID:11004777 |
| RNA Symbol: | hsa-miR-3607-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-3607-3p |
| RNA ID: | miRBase:MIMAT0017985 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11004778 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
| RLID-D:11000882 | Microvesicle | Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-3607-3p | Medulloblastoma | MNDR-E-MI-43183 |
| MNDR | hsa-miR-3607-3p | Alzheimer disease | MNDR-E-MI-43184 |
| MNDR | hsa-miR-3607-3p | Parkinson disease | MNDR-E-MI-43185 |
| MNDR | hsa-miR-3607-3p | Pancreatic cancer | MNDR-E-MI-43186 |
| MNDR | hsa-miR-3607-3p | Rectum adenocarcinoma | MNDR-E-MI-43187 |
| MNDR | hsa-miR-3607-3p | Glioblastoma | MNDR-E-MI-43188 |
| MNDR | hsa-miR-3607-3p | Lung squamous cell carcinoma | MNDR-E-MI-43189 |
| MNDR | hsa-miR-3607-3p | Lung adenocarcinoma | MNDR-E-MI-43190 |
| MNDR | hsa-miR-3607-3p | Adrenocortical carcinoma | MNDR-E-MI-43191 |
| MNDR | hsa-miR-3607-3p | Thyroid carcinoma | MNDR-E-MI-43192 |
| MNDR | hsa-miR-3607-3p | Bladder urothelial carcinoma | MNDR-E-MI-43193 |
| MNDR | hsa-miR-3607-3p | Carcinoma renal cell | MNDR-E-MI-43194 |
| MNDR | hsa-miR-3607-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-43195 |
| MNDR | hsa-miR-3607-3p | Cholangiocarcinoma | MNDR-E-MI-43196 |
| MNDR | hsa-miR-3607-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-43197 |
| MNDR | hsa-miR-3607-3p | Hepatocellular carcinoma | MNDR-E-MI-43198 |
| MNDR | hsa-miR-3607-3p | Skin cutaneous melanoma | MNDR-E-MI-43199 |
| MNDR | hsa-miR-3607-3p | Skin melanoma | MNDR-E-MI-43200 |
| MNDR | hsa-miR-3607-3p | Colorectal cancer | MNDR-E-MI-43201 |
TOP